Get the Stockscreener App
2.01
2.20%
-0.04
Immutep Limited Adr stock is traded at $2.01, with a volume of 36,939.
It is down -2.20% in the last 24 hours and up +10.16% over the past month.
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
See More
Previous Close:
$2.05
Open:
$2.05
24h Volume:
36,939
Relative Volume:
0.33
Market Cap:
$296.59M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-8.9453
EPS:
-0.2247
Net Cash Flow:
-
1W Performance:
+4.97%
1M Performance:
+10.16%
6M Performance:
-32.72%
1Y Performance:
+0.75%
1-Day Range:
$1.99
$2.05
1-Week Range:
$1.92
$2.07
52-Week Range:
$1.66
$3.335
Immutep Limited Adr Stock (IMMP) Company Profile
Compare IMMP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IMMP
Immutep Limited Adr
|
2.015 | 296.59M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
459.48 | 119.71B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
748.95 | 82.77B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
611.16 | 37.02B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
249.88 | 32.26B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
116.94 | 28.24B | 3.30B | -501.07M | 1.03B | -2.1146 |
Immutep Limited Adr Stock (IMMP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-17-24 | Initiated | CapitalOne | Overweight |
| Aug-03-23 | Initiated | Robert W. Baird | Outperform |
| Aug-03-21 | Initiated | Ladenburg Thalmann | Buy |
| Jul-16-21 | Resumed | Maxim Group | Buy |
| Sep-28-18 | Initiated | B. Riley FBR | Buy |
| Feb-15-18 | Reiterated | Maxim Group | Buy |
View All
Immutep Limited Adr Stock (IMMP) Latest News
Immutep Quarterly Activities Report Q1 FY25 - GlobeNewswire
Immutep Announces First-in-Human Phase I Study of IMP761 Progresses to Dose Escalation Portion of Trial - The Manila Times
Immutep to Participate in the 2024 Maxim Healthcare Virtual Summit - GlobeNewswire Inc.
Immutep Limited ADR (IMMP) Stock: Navigating a Year of Stock Volatility - The InvestChronicle
Metric Deep Dive: Understanding Immutep Limited ADR (IMMP) Through its Ratios - The Dwinnex
Immutep reports positive results in cancer study - Investing.com
Dow Jumps Over 200 Points; NY Empire State Manufacturing Index Increases In September - Benzinga
Research Analysts Issue Forecasts for Immutep Limited’s FY2025 Earnings (NASDAQ:IMMP) - Defense World
Immutep Limited ADR (IMMP) Stock: Navigating a Year of Volatility - The InvestChronicle
Short Interest in Immutep Limited (NASDAQ:IMMP) Declines By 10.1% - Defense World
Immutep Announces First Participant Dosed in Phase I Study of IMP761, a First in Class Agonist LAG-3 Antibody - GlobeNewswire
Virtu Financial LLC Buys 32,864 Shares of Immutep Limited (NASDAQ:IMMP) - Defense World
Immutep reports steady progress in Q4 FY24 - Investing.com India
Immutep reports steady progress in Q4 FY24 By Investing.com - Investing.com Australia
Immutep Limited (NASDAQ:IMMP) Shares Acquired by BNP Paribas Financial Markets - Defense World
Immutep Announces Successful Meeting with FDA on Phase III Design in Non-Small Cell Lung Cancer - GlobeNewswire
Guess which ASX healthcare stock is surging on big FDA news - The Motley Fool
Why 29Metals, Immutep, Insignia, and Perenti shares are pushing higher today - The Motley Fool
FY2027 EPS Estimates for Immutep Limited (NASDAQ:IMMP) Cut by Capital One Financial - American Banking and Market News
Equities Analysts Set Expectations for Immutep Limited’s FY2029 Earnings (NASDAQ:IMMP) - Defense World
Immutep Limited (NASDAQ:IMMP) Short Interest Up 6.2% in June - Defense World
Immutep Receives Regulatory Clearance for Phase I Study of - GlobeNewswire
Get in on Immutep Limited ADR’s (IMMP) buy-in window today! - SETE News
Immutep Limited ADR: Weathering Stock Market Storms with 257.67M Market Cap - The InvestChronicle
Examining IMMP’s book value per share for the latest quarter - US Post News
Immutep (IMMP) Up as Combo Therapy Meets Carcinoma Study Goals - Zacks Investment Research
Immutep Limited ADR Inc. (IMMP) Price Performance: A Technical Analysis Perspective - The InvestChronicle
Why Is Australia Based Immutep's Stock Soaring On Friday?Immutep (NASDAQ:IMMP) - Benzinga
Why Ericsson Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga
Why Immutep, Kingsgate, Netwealth, and Ora Banda shares are storming higher - The Motley Fool
Why is this ASX healthcare stock rocketing 25% on Friday? - The Motley Fool
Immutep Reports Positive Results in First Line Head and - GlobeNewswire Inc.
Balance Sheet Breakdown: Immutep Limited ADR (IMMP)'s Debt-to-Equity and Long-Term Debt/Eq Ratios – DWinneX - The Dwinnex
Immutep Limited (NASDAQ:IMMP) Short Interest Up 6.6% in June - Defense World
Holdings of Immutep Limited ADR (IMMP) are aligned with the stars – Sete News - SETE News
Market cap of Blue Star Foods Corp [BSFC] reaches 2.18M – now what? – The DBT News - The DBT News
Guggenheim lifts Invivyd Inc [IVVD] price estimate. Who else is bullish? – The DBT News - The DBT News
Chegg Inc [CHGG] stock Downgrade by Jefferies analyst, price target now $4 – The DBT News - The DBT News
Immutep Limited ADR (IMMP) Stock: Uncovering a 52-Week Range and Trading Volume - The InvestChronicle
IMMP's price-to-book ratio: An indicator of the company's performance – US Post News - US Post News
Baird cuts Immutep stock target on phase 2b trial results, retains Outperform - Investing.com
Immutep licenses new anti-cancer molecules from Cardiff University - Investing.com India
Short Interest in Immutep Limited (NASDAQ:IMMP) Increases By 5.1% - Defense World
Immutep Limited ADR Inc. (IMMP) Price Performance: A Comparative Analysis with Competitors - The InvestChronicle
Immutep Limited ADR (IMMP) Stock: A Comprehensive 52-Week Review - The InvestChronicle
Quarterly Snapshot: Quick and Current Ratios for Immutep Limited ADR (IMMP) – DWinneX - The Dwinnex
Immutep slips after stock offering - MSN
Immutep stock slips after share offering (NASDAQ:IMMP) - Seeking Alpha
Stocks of the Hour: Immutep, INOVIQ, Eastern Metals - Finance News Network
Immutep Announces Clinical Collaboration with MSD to Evaluate Efti in Combination with KEYTRUDA® (pembrolizumab) in Pivotal Phase III Trial - GlobeNewswire
Stocks of the Hour: Adherium, Nanoveu, Nimy Resources - ShareCafe
Immutep Limited Adr Stock (IMMP) Financials Data
There is no financial data for Immutep Limited Adr (IMMP). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.89%
0.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):